Press Releases

SSM Health partners with Inbound Health to offer in-home advanced care to patients

Inbound Health and SSM Health have partnered up to offer post-hospital in-home health care services to patients. The SSM Health at Home program – Recovery Care at Home – will apply to certain patients who are ready to be discharged but who still need services traditionally offered in a skilled nursing facility. Phase one of the partnership kicked off at SSM Health St. Mary’s Hospital – Madison in April 2024. Dr. James Lehman, SSM Health Wisconsin Regional Clinical Program Medical Director commented on the health benefits...

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and financial results of their companies.  “I’m honored to receive this incredible recognition from Modern Healthcare,” said Feyi Ayodele in a press release on Tuesday. “I want to thank our team, investors, partners, and most importantly, our customers for believing in me and for...

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient demographics.  The research effort seeks to better understand the eligibility of patients for immune checkpoint inhibitor (ICI) therapy, a type of cancer treatment that boosts the body’s ability to battle cancerous cells. The project will begin by examining over 20,000 patients with “solid tumor malignancies,” and will then...

Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements

On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional collaboration, among others. These changes are the latest in a long line of the company’s efforts to improve the way that clinical trials and medical research is performed.  Chief Technology Officer and Chief Product Officer Lisa Moneymaker expressed her excitement with the announcement in Monday’s press release, saying,...

PM360 Announces the Selections for its 12th Annual Innovations Issue

On Thursday, December 14th, pharmaceutical marketing and trade magazine PM360 announced its list of innovators in the pharmaceutical, biotechnology, medical device, and biotechnology industries. These innovators were named for their achievements across a variety of areas, including Artificial Intelligence, Clinical Trials, Startups, and more, and included RxLightning as one of the innovators in the “Startups” category.  Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360, expressed her excitement with this year’s list of innovators in the company’s press release, stating, “We know the importance of innovation, which...

ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform

Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple myeloma using data from Aster Avatar, including a longitudinal study of response to anti-BCMA CAR-T treatment. “ASH is a unique opportunity to demonstrate the impactful discoveries resulting from ORIEN and Aster Insights’ discovery solutions,” said Anand Shah, MD, CEO of Aster Insights. “This year, we...

New Study Shows Point-of-care Genetics May Improve Uptake, Reduce Racial Disparities

On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This study aims to identify which racial and ethnic groups are not receiving the necessary counseling and treatment and to explore ways in which this disparity can be improved.  Data from this study was collected from over 14,000 patients across 15 clinical sites and six states, identifying issues,...

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

Telemedicine company Hims & Hers announced the launch of its new weight loss service, “Weight Loss by Hims & Hers,” in a press release on Monday, December 4, 2023. The new service aims to establish itself as a holistic alternative to traditional weight loss strategies, emphasizing users’ individual goals, biology, and unique medical & health circumstances to create a tailor-made weight loss strategy specifically for them.  As part of its new weight loss service, Hims & Hers also announced that it had made a key hire...

Aledade and Anthem Announce New Medicaid Partnership to Bring the Benefits of Value-Based Care to More Virginians

On Thursday, November 30, 2023, Aledade Inc. announced that it has partnered with Anthem Blue Cross and Blue Shield to increase quality and ease of access for patient care to people throughout the Commonwealth of Virginia. The initiative will provide improved and more accessible healthcare to more than 150,000 Virginia residents and will affect more than 80 practices, 15 health centers, and 25 rural health clinics throughout the greater Virginia area.  “Every patient deserves access to the proven benefits of physician-led, value-based care”, said Ananya Banerjee,...

Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform

Densitas Inc, an artificial intelligence and technology company, announced on Sunday that it has partnered with the cancer prevention service CancerIQ to include Cancer IQ’s Tyrer-Cuzick Version 8 risk calculator in its breast cancer screening offerings. This 8th version, released in March of 2018, uses further-improved patient and historical data to predict the likelihood of future breast cancer diagnoses. Founder and CEO of Densitas Inc. Mo Abdolell expressed his excitement with the announcement in the press release, stating, “Our collaboration with CancerIQ reflects our commitment to...